Dupont A G, Lefebvre R A, Vanderniepen P
Br J Pharmacol. 1987 Jul;91(3):493-501. doi: 10.1111/j.1476-5381.1987.tb11242.x.
The effect of local administration of the dopamine 2 (DA2)-receptor agonist quinpirole and of the DA1-receptor agonist fenoldopam was studied in the in situ, constant flow autoperfused, superior mesenteric vascular bed of the rat. Local infusion of quinpirole (30 micrograms kg-1 min-1 for 5 min) had no effect on baseline perfusion pressure; it reduced the pressor responses to electrical stimulation (4 Hz, 1 ms, supramaximal voltage) of the periarterial sympathetic nerves to 45.6 +/- 2.1% of its original value but did not modify similar pressor responses produced by locally administered noradrenaline. The inhibitory effect of quinpirole was antagonized by the selective DA2-receptor antagonist domperidone (10 micrograms kg-1) but not by the selective DA1-receptor antagonist SCH 23390 (50 micrograms kg-1). Local infusion of fenoldopam (30 micrograms kg-1 min-1 for 5 min) reduced baseline perfusion pressure to 89.9 +/- 1.9%, increased the pressor response to electrical stimulation (4 Hz, 1 ms, supramaximal voltage) of the periarterial nerves to 134.7 +/- 14.0%, but reduced the pressor response to locally administered noradrenaline to 37.2 +/- 8.2%. Similar pressor responses induced by the selective alpha 1-adrenoceptor agonist phenylephrine were also reduced by fenoldopam (to 38.4 +/- 6.4%), but responses to locally administered angiotensin II were not modified. Pretreatment with SCH 23390 (50 micrograms kg-1) antagonized the effect of fenoldopam on baseline perfusion pressure, but had no influence on the effect of fenoldopam on responses to electrical stimulation or to noradrenaline. Pretreatment with the selective alpha 2-adrenoceptor antagonist rauwolscine (100 micrograms kg-1) had no effect on the reduction in baseline perfusion pressure induced by fenoldopam nor on its inhibitory effect on the response to noradrenaline, but it antagonized the stimulatory effect of fenoldopam on the response to electrical stimulation. 7 The results show that quinpirole inhibits neurogenic vasoconstriction in the rat superior mesenteric vascular bed through stimulation of presynaptic DA2-receptors while fenoldopam stimulates postsynaptic vasodilatory DA,-receptors. In addition, our results suggest that the inhibitory effect of fenoldopam on the vasoconstrictor response to noradrenaline may be due to an antagonistic action at postsynaptic alpha-adrenoceptors, while its potentiating effect on neurogenic vasoconstriction is due to blockade of presynaptic alpha 2-adrenoceptors.
在大鼠原位、恒流自动灌注的肠系膜上血管床中,研究了多巴胺2(DA2)受体激动剂喹吡罗和DA1受体激动剂非诺多泮局部给药的作用。局部输注喹吡罗(30微克/千克·分钟,持续5分钟)对基础灌注压无影响;它将动脉周围交感神经电刺激(4赫兹,1毫秒,超最大电压)引起的升压反应降低至其原始值的45.6±2.1%,但不改变局部给予去甲肾上腺素产生的类似升压反应。喹吡罗的抑制作用被选择性DA2受体拮抗剂多潘立酮(10微克/千克)拮抗,但未被选择性DA1受体拮抗剂SCH 23390(50微克/千克)拮抗。局部输注非诺多泮(30微克/千克·分钟,持续5分钟)将基础灌注压降低至89.9±1.9%,将动脉周围神经电刺激(4赫兹,1毫秒,超最大电压)引起的升压反应增加至134.7±14.0%,但将局部给予去甲肾上腺素引起的升压反应降低至37.2±8.2%。选择性α1肾上腺素能受体激动剂去氧肾上腺素诱导的类似升压反应也被非诺多泮降低(至38.4±6.4%),但对局部给予血管紧张素II的反应未改变。用SCH 23390(50微克/千克)预处理可拮抗非诺多泮对基础灌注压的作用,但对非诺多泮对电刺激或去甲肾上腺素反应的作用无影响。用选择性α2肾上腺素能受体拮抗剂萝芙木碱(100微克/千克)预处理对非诺多泮引起的基础灌注压降低及其对去甲肾上腺素反应的抑制作用无影响,但它拮抗了非诺多泮对电刺激反应的刺激作用。结果表明,喹吡罗通过刺激突触前DA2受体抑制大鼠肠系膜上血管床的神经源性血管收缩,而非诺多泮刺激突触后血管舒张性DA1受体。此外,我们的结果表明,非诺多泮对去甲肾上腺素血管收缩反应的抑制作用可能是由于对突触后α肾上腺素能受体的拮抗作用,而其对神经源性血管收缩的增强作用是由于对突触前α2肾上腺素能受体的阻断作用。